|
KMID : 0918520160160020057
|
|
Journal of the Korean Society of Inherited Metabolic Disease
2016 Volume.16 No. 2 p.57 ~ p.61
|
|
|
The Strategy for Diagnosis and Treatment of Isovaleric Acidemia
|
|
Ko Jung-Min
Lee Kyung-A
|
|
|
Abstract
|
|
|
Isovaleric acidemia (IVA) is an autosomal recessively inherited organic acid disorder due to a defect of
the enzyme isovaleryl-CoA dehydrogenase in the leucine metabolic pathway. Deficiency of this enzyme results in the accumulation of derivatives of isovaleryl-CoA. In acute illness in IVA, isovaleric acid and its derivatives accumulate and profound metabolic acidosis with ketosis, characteristic pungent body odor, hypoglycemia, and hyperammonemia can be developed. Additionally, recurrent vomiting, failure to thrive, developmental delay, epilepsy and mental retardation are chronic presenting symptoms and signs for IVA. On the result of newborn screening for inherited metabolic disorders, increased levels of isovalerylcarnitine (C5) are shown. However, C5 elevation can be accompanied with short/branched-chain acyl-CoA dehydrogenase (SBCAD) and therapy with certain antibiotics containing pivalic acid. Quantitative measurement of organic acids in urine and acylcarnitine profiles in plasma are necessary to differential diagnosis. Molecular genetic analysis of the IVD gene for IVA and ACADSB is also helpful to confirm IVA and SBCAD deficiency, respectively. Considering that IVA can be associated with significant morbidity and mortality at acute presentation of metabolic crisis, early diagnosis prior to the onset of symptoms by newborn screening enable to introduction of early treatment and prevention of acute and chronic complications.
|
|
|
KEYWORD
|
|
|
Isovaleric acidemia, Leucine, Metabolic acidosis, Hyperammonemia, Newborn screening
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|